On Tuesday, May 27, an analyst from Truist Securities initiated coverage on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with a Buy…
Tag: Teva
Teva gives aggressive guidance for innovative drugs
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) held an “Innovation and Strategy Day” today, in which it discussed…
Teva recycling debt after rating upgrade
Several days after Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) was upgrade by ratings agency Moody’s, the Israeli…
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize…
Trump post on slashing drug prices sends Teva tumbling
The share price of Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) is down by 7% in Tel Aviv this…
Teva to lay off an estimated 250-300 employees in Israel
Last week Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) published its first quarter results for 2025 and unexpectedly…
Teva to lay off 3,000 employees
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced that it will lay off 3,000 employees worldwide over…
Teva jumps on FDA approval for biosimilar
The share price of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is rising sharply after the company reported…
Prilenia signs deal for former Teva ALS drug worth up to 500m
Israeli-Dutch clinical stage biotech company Prilenia Therapeutics has announced a collaboration and licensing agreement for its lead drug Pridopidine,…
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…